Previous Close | 0.3700 |
Open | 0.3700 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.3700 - 0.3700 |
52 Week Range | 0.2990 - 0.6957 |
Volume | |
Avg. Volume | 3,201 |
Market Cap | 28.044M |
Beta (5Y Monthly) | 0.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0700 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, BC / ACCESSWIRE /April 9, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") today announces that it has licensed a novel biosensing architecture from the University of British Columbia. This licence is the ...
VANCOUVER, BC / ACCESSWIRE / April 2, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the signing of a license agreement with a significant global diagnostics company. The license agreement is ...
VANCOUVER, BC / ACCESSWIRE / March 21, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide a strategic update and outlook for 2024 and beyond. The Company is beginning to see results from its 2023 ...